The short version
- In 2,362 women followed for four years, perimenopausal cognitive change showed up as a pause in the usual practice-effect improvement rather than a loss, and performance rebounded after the transition.
- A separate study of 117 women found the lowest scores on verbal learning, memory, attention and fine motor speed in the first year after the final period, so exactly where the low point sits is unsettled.
- Sleep, iron and thyroid produce fog that looks identical to hormonal fog, and a Colorado screen of 25,862 people found elevated TSH in 9.5% of them.
- Forty per cent of people already taking thyroid medication in that screening had an abnormal TSH, and individual symptoms had low sensitivity, so this is a blood test rather than a self-assessment.
- The lion's mane trial most often cited gave 30 adults with mild cognitive impairment roughly 3g of dried mushroom powder daily for 16 weeks, and the benefit was gone four weeks after stopping.
The word that won't come. The reason you walked into the room. If you're somewhere in your forties and quietly worried about it, the most useful thing anyone can give you is the correct name for it — and the timeline.
Cognitive changes through the menopausal transition are well documented, and the pattern in longitudinal research is that performance dips during the transition and then recovers afterwards. It tracks the transition rather than marking permanent decline. Knowing that changes how the whole experience feels.
What the largest study actually measured
The precise version is more reassuring than the summary, so it's worth walking through. Greendale and colleagues followed 2,362 women in the Study of Women's Health Across the Nation for four years, testing processing speed, verbal memory and working memory repeatedly over that period, and published the result in Neurology.
What they found was not that women got worse. It was that they stopped getting better. Premenopausal, early perimenopausal and postmenopausal women all improved their processing-speed scores across repeated testing — the ordinary practice effect of sitting the same test again. Late perimenopausal women did not. Verbal memory climbed during premenopause and during postmenopause, and flattened through early and late perimenopause. The subjective experience of "I used to be sharper than this" turns out to correspond to a measurable pause in learning, not to loss.
And then it came back. Performance rebounded to premenopausal levels after the transition, which is what led the authors to describe the difficulties as time-limited. That is the sentence worth holding onto: a documented plateau, in over two thousand women, in a specific window, with an end.
The picture isn't perfectly clean, and you should hear that from us rather than discover it later. A 2013 study of 117 women in the Rochester Investigation of Cognition Across Menopause found that cognition does not change linearly across perimenopause at all: the women scoring worst on verbal learning, verbal memory, attention and fine motor speed were those in their first year after the final period, not those mid-transition. Different design, different sample, a different answer about exactly where the low point sits. What the two agree on is that there is a window, and that it is a window.
Rule these out first — we mean it
Sleep, iron and thyroid. All three cause fog that looks identical to hormonal fog, all three are markedly more common in women, and all three are a blood panel and a conversation away. We would genuinely rather you find a treatable cause than take our capsules for a year.
On thyroid, the numbers justify the nagging. The Colorado thyroid disease prevalence study screened 25,862 people at a statewide health fair and found elevated TSH in 9.5% of them. It also found that 40% of the people already taking thyroid medication had abnormal TSH — so "I'm being treated for that" is not the same as "I'm in range." The detail that matters most if you're trying to reason your way to an answer at home: individual symptoms had low sensitivity. You cannot work this out from how you feel. It is a blood test, it is cheap, and the paper's own conclusion is that thyroid dysfunction is common and often goes undetected.
If those come back clear
Lion's mane is the ingredient with the most interesting human data here. The Mori 2009 double-blind placebo-controlled trial gave adults aged 50–80 with mild cognitive impairment 250mg tablets three times daily for 16 weeks; the supplemented group scored higher on cognitive scales at weeks 8, 12 and 16. Notably, the benefit was not present at follow-up four weeks after stopping — suggesting continued use matters.
Two things about that trial you should know before you shop on the strength of it. The dose was much larger than the shorthand implies: participants took four 250mg tablets three times a day, which is roughly 3g of dried mushroom powder daily, not 250mg. A great many capsules on the market deliver a small fraction of that, and a fraction of a dose is not a smaller version of the result. Second, the trial randomised 30 people into two groups of 15. That is a small study. Interesting, not decisive, and you should have the sample size before you have the bottle.
Newer work in healthy young adults is more mixed, which is worth knowing before you expect a transformation. Treat lion's mane as a modest, gradual support, not a switch.
If you do try it: the effect in Mori's trial grew with duration and was gone four weeks after stopping, so judge it somewhere between eight and sixteen weeks of daily use rather than at two. And judge it on something specific — whether the word arrives, whether you finish the thought you started — rather than on a general sense of sharpness, which is the easiest thing in the world to talk yourself into feeling.
Good questions
Is perimenopause brain fog permanent?
The longitudinal data says no. Following 2,362 women for four years, processing speed and verbal memory stopped improving during the transition rather than declining, then rebounded to premenopausal levels afterwards, which is why the authors described the difficulties as time-limited. A smaller study placed the low point in the first year after the final period instead. What both agree on is that there is a window, and that it is a window.
How do I know if it's hormones or something else?
You cannot work it out from how you feel, which is the whole problem. Sleep, iron and thyroid all cause fog that looks identical to hormonal fog, all three are markedly more common in women, and all three are a blood panel away. In the Colorado screening of 25,862 people, individual symptoms had low sensitivity for thyroid dysfunction. Rule those out first. We would rather you found a treatable cause.
Should I get my thyroid checked even if I'm already being treated for it?
Yes. In a screening of 25,862 people, 40% of those already taking thyroid medication had an abnormal TSH. Being treated for a thyroid condition is not the same as being in range. The paper's own conclusion was that thyroid dysfunction is common and often goes undetected. It is a cheap test and it belongs with a clinician who can read it against everything else.
Does lion's mane actually help with brain fog?
The human data is interesting rather than decisive. The trial people cite randomised 30 adults aged 50 to 80 with mild cognitive impairment into two groups of 15, and the supplemented group scored higher at weeks 8, 12 and 16. Newer work in healthy young adults is more mixed. Treat lion's mane as a modest, gradual support, not a switch, and have the sample size in mind before you have the bottle.
How much lion's mane do I need to take?
Far more than the shorthand implies. Participants in that trial took four 250mg tablets three times a day, which is roughly 3g of dried mushroom powder daily, not 250mg. A great many capsules on the market deliver a small fraction of that, and a fraction of a dose is not a smaller version of the result. Check the actual daily amount on the label before you compare prices.
How long before I know if it's doing anything?
Judge it between eight and sixteen weeks of daily use, not at two. The effect in that trial grew with duration and was no longer present four weeks after stopping, which suggests continued use matters. Judge it on something specific too, like whether the word arrives or whether you finish the thought you started, rather than on a general sense of sharpness that is easy to talk yourself into.
Sources
- Mori K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res, 2009. View study
- The Acute and Chronic Effects of Lion's Mane Supplementation on Cognitive Function, Stress and Mood in Young Adults. 2023. View study
- Greendale GA, et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 2009. View study
- Weber MT, Rubin LH, Maki PM. Cognition in perimenopause: the effect of transition stage. Menopause, 2013. View study
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med, 2000. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
